» Articles » PMID: 26317758

Trans-Corneal Subretinal Injection in Mice and Its Effect on the Function and Morphology of the Retina

Overview
Journal PLoS One
Date 2015 Aug 29
PMID 26317758
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To introduce a practical method of subretinal injection in mice and evaluate injection-induced retinal detachment (RD) and damage using a dynamic imaging system, electrophysiology, and histology.

Methods: After full dilation of a 2-month-old C57BL/6J mouse pupil, the cornea near the limbus was punctured with a 30 ½-gague disposable beveled needle. A 33 ½-gauge blunt needle was inserted through the corneal perforation into the anterior chamber, avoiding the lens before going deeper into the vitreous cavity, and penetrating the inner retina to reach the subretinal space. The mice were divided into four groups: in group 1, about 80-100% of the retina was filled with subretinally injected solution; in group 2, approximately 50-70% of the retina was filled with injected solution; in group 3, the procedures were stopped before solution injection; and non-injected eyes were used as the negative control in group 4. An optical coherence tomography (OCT) imaging system was used to monitor retinal reattachment during the first three days following the injections. Histological and functional changes were examined by light microscopy and electroretinography (ERG) at five weeks post-injection.

Results: After a short-term training, a 70% success rate with 50% or more coverage (i.e., retinal blebs occupied 50% or more retinal area and filled with the injected solution) with minimal injection-related damages can be achieved. Bleb formation was associated with retinal detachment (RD) between the neuroretina and the retinal pigment epithelium (RPE) layer. Partial RD could be observed at post-injection day 1, and by day 2 most of the retina had reattached. At 5 weeks post-injection, compared to uninjected control group 4, the b-wave amplitudes of ERG decreased 22% in group 1, 16% in group 2, and 7% in group 3; the b-wave amplitudes were statistically different between the uninjected group and the groups with either 50-70% or 80-100% coverage. The subretinal injection-induced RD reattached and became stable at five weeks post-injection, although some photoreceptor damage could still be observed in and around the injection sites, especially in 80-100% coverage group.

Conclusions: Trans-corneal subretinal injection is effective and practical, although subretinal injection-related damages can cause some morphological and functional loss.

Citing Articles

A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases.

Alsalloum A, Gornostal E, Mingaleva N, Pavlov R, Kuznetsova E, Antonova E Cells. 2024; 13(20.

PMID: 39451224 PMC: 11506034. DOI: 10.3390/cells13201706.


Seeing the Future: A Review of Ocular Therapy.

Whalen M, Akula M, McNamee S, Deangelis M, Haider N Bioengineering (Basel). 2024; 11(2).

PMID: 38391665 PMC: 10886198. DOI: 10.3390/bioengineering11020179.


Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model.

Liu Y, Li K, Li Z, Lu Y, McNally M, Esposito E J Vis Exp. 2024; (203).

PMID: 38345250 PMC: 11294988. DOI: 10.3791/65448.


Unlocking therapeutic potential: dual gene therapy for ameliorating the disease phenotypes in a mouse model of Leber congenital amaurosis.

Liu Y, Tai J, Yu C, Xu D, Xiao D, Pang J Front Med (Lausanne). 2024; 10:1291795.

PMID: 38264046 PMC: 10803578. DOI: 10.3389/fmed.2023.1291795.


Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.

Parsons N, Annamalai B, Rohrer B Transl Vis Sci Technol. 2023; 12(7):17.

PMID: 37462980 PMC: 10362922. DOI: 10.1167/tvst.12.7.17.


References
1.
Pang J, Dai X, Boye S, Barone I, Boye S, Mao S . Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa. Mol Ther. 2010; 19(2):234-42. PMC: 3034861. DOI: 10.1038/mt.2010.273. View

2.
Nour M, Quiambao A, Peterson W, Al-Ubaidi M, Naash M . P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci. 2003; 44(10):4505-14. PMC: 2937827. DOI: 10.1167/iovs.03-0453. View

3.
Stieger K . tgAAG76, an adeno-associated virus delivered gene therapy for the potential treatment of vision loss caused by RPE65 gene abnormalities. Curr Opin Mol Ther. 2010; 12(4):471-7. View

4.
Dai X, Han J, Qi Y, Zhang H, Xiang L, Lv J . AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice. Invest Ophthalmol Vis Sci. 2014; 55(3):1724-34. PMC: 3968931. DOI: 10.1167/iovs.13-13654. View

5.
Li X, Li W, Dai X, Kong F, Zheng Q, Zhou X . Gene therapy rescues cone structure and function in the 3-month-old rd12 mouse: a model for midcourse RPE65 leber congenital amaurosis. Invest Ophthalmol Vis Sci. 2010; 52(1):7-15. PMC: 3053305. DOI: 10.1167/iovs.10-6138. View